Previous close | 35.19 |
Open | 35.14 |
Bid | 34.97 x 800 |
Ask | 35.05 x 900 |
Day's range | 34.61 - 37.14 |
52-week range | 27.77 - 138.52 |
Volume | |
Avg. volume | 1,209,616 |
Market cap | 2.462B |
Beta (5Y monthly) | 1.59 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.59 |
Earnings date | 08 Aug 2022 - 12 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 99.20 |
One thing we could say about the analysts on Beam Therapeutics Inc. ( NASDAQ:BEAM ) - they aren't optimistic, having...
Beam Therapeutics Inc. (BEAM) delivered earnings and revenue surprises of 8.18% and 89.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Aeglea (AGLE) delivered earnings and revenue surprises of -5.71% and 6.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?